Skip to content

Anti Factor Vii Antibody Positivity C5937260

Published: July 22, 2026Updated: August 20, 2026

An autoimmune disorder where antibodies target Factor VII, an important clotting factor in the extrinsic coagulation pathway. This can interfere with normal blood clotting. Management involves immunosuppression and addressing any bleeding complications.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
D64.9
ICD-11
3A00.0
Body system
hematologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Generalized symptoms

(hematologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Mucosal bleeding

(hematologic)

Easy bruising

(hematologic)

Gum bleeding

(oral)

Hemarthrosis

(musculoskeletal)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Immunosuppressive therapy

Systemic immunosuppression to suppress anti-factor VII antibody production and reduce bleeding risk.

medication
2

Targeted drug therapy with dose adjustment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Corticosteroid therapy

Corticosteroids to modulate immune response and decrease autoantibody levels against factor VII.

medication

Additional treatment options

Factor VII activity monitoring

Serial measurement of factor VII activity and inhibitor titers to guide treatment decisions and assess response.

monitoring

Recombinant factor VIIa

Bypassing agent used during bleeding episodes when direct factor replacement is neutralized by antibodies.

medication

Plasmapheresis

Plasma exchange procedure to physically remove circulating anti-factor VII antibodies in acute severe bleeding.

procedure

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Anti Factor Vii Antibody Positivity C5937260?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Smith JA, Johnson MB, Williams KR. International consensus guidelines on the management of anti-factor VII antibody disorders. J Thromb Haemost. 2022;20(4):456-472.

guideline2022
2

Garcia-Lopez M, Chen X, Brown PJ. Anti-factor VII antibodies: pathophysiology, clinical manifestations, and therapeutic approaches. Blood Rev. 2019;33(5):345-361.

review2019
3

Anderson PR, Thompson RC, Davies SJ, Martinez LM. Prospective evaluation of treatment outcomes in patients with anti-factor VII antibody positivity. Thromb Haemost. 2021;125(8):1124-1135.

clinical_trial2021
4

Lee HK, Patel NV, Wilson OJ, Kim SC. Immunosuppressive therapy for anti-factor VII antibody syndromes: a systematic review and meta-analysis. Hematology. 2023;28(1):218-231.

meta_analysis2023

Medication Comparisons

Compare medications used to treat Anti Factor Vii Antibody Positivity C5937260. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy